Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Weave Signs First-Of-Its-Kind Integration Partnership With Provet Cloud; Terms Not Disclosed
Weave (NYSE:WEAV), the all-in-one customer communication platform for small business, today announced it has signed an integration partnership agreement with Provet Cloud, by Nordhealth, a practice management solution
Weave Names Brett White As President, COO
Weave (NYSE:WEAV), a leading all-in-one customer communications and engagement software platform for small and medium-sized businesses, announced two new additions to its leadership today. Weave's expansion of its
Expert Ratings for Weave Communications
Over the past 3 months, 6 analysts have published their opinion on Weave Communications (NYSE:WEAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Goldman Sachs Maintains Neutral on Weave Communications, Lowers Price Target to $8
Goldman Sachs maintains Weave Communications (NYSE:WEAV) with a Neutral and lowers the price target from $13 to $8.
Where Weave Communications Stands With Analysts
Weave Communications (NYSE:WEAV) has observed the following analyst ratings within the last quarter:
Stifel Maintains Buy on Weave Communications, Lowers Price Target to $12
Stifel analyst Parker Lane maintains Weave Communications (NYSE:WEAV) with a Buy and lowers the price target from $14 to $12.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.